Blumenkranz Mark S. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-24 2:27 pm Purchase | 2021-11-15 | 13D | Kala Pharmaceuticals, Inc. KALA | Blumenkranz Mark S. | 213,645 7.300% | 213,645 (New Position) | Filing |